Anticancer drugs: recent strategies to improve stability profile, pharmacokinetic and pharmacodynamic properties

G Ioele, M Chieffallo, MA Occhiuzzi, M De Luca… - Molecules, 2022 - mdpi.com
In past decades, anticancer research has led to remarkable results despite many of the
approved drugs still being characterized by high systemic toxicity mainly due to the lack of …

Dose adjustment in patients with liver disease

F Delco, L Tchambaz, R Schlienger, J Drewe… - Drug safety, 2005 - Springer
Unfortunately, there is no endogenous marker for hepatic clearance that can be used as a
guide for drug dosing. In order to predict the kinetic behaviour of drugs in cirrhotic patients …

[图书][B] DeVita, Hellman, and Rosenberg's cancer: principles & practice of oncology

VT DeVita, TS Lawrence, SA Rosenberg - 2008 - books.google.com
Acclaimed by the worldwide medical community as" a staple reference text in the medical
oncologist's library"(JAMA), DeVita, Hellman, and Rosenberg's Cancer: Principles and …

Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia

A Egbelakin, MJ Ferguson, EA MacGill… - Pediatric blood & …, 2011 - Wiley Online Library
Background This study evaluates the relationship between cytochrome P450 (CYP) 3A5
genotype and vincristine‐induced peripheral neuropathy (VIPN) in children with precursor B …

Anti-breast cancer agents derived from plants

DO Levitsky, VM Dembitsky - Natural products and bioprospecting, 2015 - Springer
Upon emergence of modern anticancer therapy, medical community is divided into two
opposite camps, one of them claiming absolute necessity of using isolated or synthesized …

Considerations in the design and development of transport inhibitors as adjuncts to drug therapy

AH Dantzig, DP de Alwis, M Burgess - Advanced drug delivery reviews, 2003 - Elsevier
With the realization of the importance of drug efflux transporters in disease processes and
treatment, development of inhibitors to these transporters has been sought for use as …

Effect of race on vincristine‐associated neurotoxicity in pediatric acute lymphoblastic leukemia patients

JL Renbarger, KC McCammack… - Pediatric blood & …, 2008 - Wiley Online Library
Background This report examines the association between race and vincristine‐associated
neurotoxicity in pediatric patients with precursor B cell acute lymphoblastic leukemia (preB …

Apoptosis-related BCL2-family members: Key players in chemotherapy

CK Kontos, MI Christodoulou… - Anti-Cancer Agents in …, 2014 - ingentaconnect.com
Classical chemotherapeutic agents such as mitotic inhibitors (spindle poisons), alkylating
agents, antimetabolites, topoisomerase inhibitors, and anthracenediones (anthracyclines) …

Long-term Outcomes of Oral Vinorelbine in Advanced, Progressive Desmoid Fibromatosis and Influence of CTNNB1 Mutational Status

O Mir, C Honoré, AN Chamseddine, J Dômont… - Clinical Cancer …, 2020 - AACR
Purpose: Desmoid-type fibromatosis (DF) are locally aggressive neoplasms, with a need for
effective systemic treatment in case of progression to avoid the short-and long-term …

Practical treatment guide for dose individualisation in cancer chemotherapy

P Canal, E Chatelut, S Guichard - Drugs, 1998 - Springer
Dosages of anticancer drugs are usually calculated on the basis of a uniform standard, the
body surface area (BSA). Although many physiological functions are proportionate to BSA …